Toronto, Ontario–(Newsfile Corp. – October 7, 2021) – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched“), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that KGK Science, a licensed contract research organization (CRO) in Canada, is commencing the next pre-clinical…


Previous articlePsygen Announces use of Psilocybin in Human Trial and Provides Update on IP Portfolio
Next articlePTSF80 – Decriminalization in Seattle, San Pedro, and The Dark Web